- Independent in relation to the Company and its management: No
- Independent in relation to major shareholders: No
Professor Ignacio Melero, University of Navarra, Spain is an expert in immunotherapy for cancer. Professor Melero´s research focuses on translational studies of e.g. the TNF receptor superfamily and clinical development of immunotherapeutic drugs.